This will be the first publication of Type 1 diabetes(T1D) outcomes in five low-middle-income countries (LMICs)-Laos, Malaysia, Vietnam, Cambodia and Myanmar in the Southeast Asia (SEA) region. The information obtained has been possible due to partnership programmes of non-government organisationAction4Diabetes (A4D) with defined local hospitalsthrough a Memorandum of Understandingsigned with the governments in SEAthat guarantees ongoing supplies of free insulin, blood glucose meter supplies, HbA1c tests and hospital emergency funds.ParticipantsBetween 2020 and 2021, 383 children and young people with T1D who were active in the A4D supported programmes were reviewed including information on health coverage, multidisciplinary team management...
Objective: Thailand has three healthcare insurance schemes, including: Universal Health Coverage (UH...
Diabetes mellitus is rapidly becoming one of the major diseases affecting people's health globally. ...
Background In 2019, the World Health Organization recognised diabetes as a clinically and pathophysi...
IntroductionIn several of the Low and Middle Income countries , many patients with Type 1 diabetes (...
Treatment of type 1 diabetes is a challenging issue in South East Asia. Unlike in the developed coun...
Aims: To describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, ...
International audienceBackgroundDiabetes is a chronic disease characterized by hyperglycemia that ca...
© 2020 Graham David OgleThere are major deficits in knowledge related to the epidemiology and care o...
Background/Objective: Diabetes Research Education and Management (DREAM) Trust (DT) is a charitable ...
Abstract Diabetes is one of the largest global health problems and exhibits a constantly increasing ...
AimsTo establish the status of diabetes control in Asia, the Diabcare- Asia 1998 study collected dat...
Aims: To improve access and quality of diabetes care for people in low-income countries, it is impor...
Two-third of the world's population lives in the Asia Pacific region where prevalence of diabetes ha...
Aims To describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, Pe...
AIM: The prevalence of diabetes mellitus among Malaysians aged � 30 years of age has increased by ...
Objective: Thailand has three healthcare insurance schemes, including: Universal Health Coverage (UH...
Diabetes mellitus is rapidly becoming one of the major diseases affecting people's health globally. ...
Background In 2019, the World Health Organization recognised diabetes as a clinically and pathophysi...
IntroductionIn several of the Low and Middle Income countries , many patients with Type 1 diabetes (...
Treatment of type 1 diabetes is a challenging issue in South East Asia. Unlike in the developed coun...
Aims: To describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, ...
International audienceBackgroundDiabetes is a chronic disease characterized by hyperglycemia that ca...
© 2020 Graham David OgleThere are major deficits in knowledge related to the epidemiology and care o...
Background/Objective: Diabetes Research Education and Management (DREAM) Trust (DT) is a charitable ...
Abstract Diabetes is one of the largest global health problems and exhibits a constantly increasing ...
AimsTo establish the status of diabetes control in Asia, the Diabcare- Asia 1998 study collected dat...
Aims: To improve access and quality of diabetes care for people in low-income countries, it is impor...
Two-third of the world's population lives in the Asia Pacific region where prevalence of diabetes ha...
Aims To describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, Pe...
AIM: The prevalence of diabetes mellitus among Malaysians aged � 30 years of age has increased by ...
Objective: Thailand has three healthcare insurance schemes, including: Universal Health Coverage (UH...
Diabetes mellitus is rapidly becoming one of the major diseases affecting people's health globally. ...
Background In 2019, the World Health Organization recognised diabetes as a clinically and pathophysi...